OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SRENH58

Swiss Re AG

ReinsuranceVerified

Swiss Re AG has a total equity of $21.14 billion and no dilution risk, as shares outstanding for both basic and diluted are identical at 294.92 million shares. The company has no debt, as indicated by a debt-to-equity ratio of 0.0, suggesting a strong capital structure and no leverage risk. In terms of profitability, Swiss Re AG's performance is not directly quantified in the provided data, but the absence of debt and the high equity base indicate a strong financial position. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the lack of debt implies a lower cost of capital and potentially higher returns on equity. Swiss Re AG operates in a global market, and its revenue is not concentrated in any specific geographic region or segment. The company's business is diversified across various insurance and reinsurance products, which helps mitigate the risk of over-reliance on a single market or product line. The company's growth trajectory is not explicitly quantified in the provided data, but the absence of debt and the high equity base suggest a stable financial position. Analysts have provided a mean price target of $129.78 and a median price target of $130.00, indicating a generally positive outlook on the company's future performance. Swiss Re AG faces low dilution risk, as there is no difference between basic and diluted shares outstanding. The company's liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents. However, the absence of debt and the high equity base suggest a strong liquidity position. Recent events and filings do not indicate any significant changes in the company's financial position or strategic direction. The company's financial stability and lack of debt suggest a conservative approach to capital management, which is typical for a reinsurance company.

30-day price · SRENH-10.75 (-8.1%)
Low$118.95High$135.90Close$121.45As of17 May, 00:00 UTC
Profile
CompanySwiss Re AG
TickerSRENH.S
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryReinsurance
AI analysis

Business. Swiss Re AG is a global reinsurance company that provides risk transfer solutions to insurance companies, helping them manage and mitigate financial risks associated with underwriting insurance policies.

Classification. Swiss Re AG is classified under the Financials economic sector, Insurance business sector, and Reinsurance industry with a confidence level of 0.92.

Swiss Re AG has a total equity of $21.14 billion and no dilution risk, as shares outstanding for both basic and diluted are identical at 294.92 million shares. The company has no debt, as indicated by a debt-to-equity ratio of 0.0, suggesting a strong capital structure and no leverage risk. In terms of profitability, Swiss Re AG's performance is not directly quantified in the provided data, but the absence of debt and the high equity base indicate a strong financial position. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the lack of debt implies a lower cost of capital and potentially higher returns on equity. Swiss Re AG operates in a global market, and its revenue is not concentrated in any specific geographic region or segment. The company's business is diversified across various insurance and reinsurance products, which helps mitigate the risk of over-reliance on a single market or product line. The company's growth trajectory is not explicitly quantified in the provided data, but the absence of debt and the high equity base suggest a stable financial position. Analysts have provided a mean price target of $129.78 and a median price target of $130.00, indicating a generally positive outlook on the company's future performance. Swiss Re AG faces low dilution risk, as there is no difference between basic and diluted shares outstanding. The company's liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents. However, the absence of debt and the high equity base suggest a strong liquidity position. Recent events and filings do not indicate any significant changes in the company's financial position or strategic direction. The company's financial stability and lack of debt suggest a conservative approach to capital management, which is typical for a reinsurance company.
Key takeaways
  • Swiss Re AG has a strong capital structure with no debt and a total equity of $21.14 billion.
  • The company faces low dilution risk, as there is no difference between basic and diluted shares outstanding.
  • Analysts have provided a generally positive outlook, with a mean price target of $129.78 and a median price target of $130.00.
  • The company's liquidity risk could not be assessed, but its strong equity position suggests a stable financial position.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity$21.14B
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.66B$1.44B$248.0M
FY-3$1.44B$472.0M-$920.0M
FY-2$3.61B$3.11B$1.34B
FY-1$3.87B$3.24B$1.30B
FY0$5.88B$4.74B$2.64B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$181.57B$23.57B$5.05B
FY-3$170.68B$12.70B$4.08B
FY-2$133.86B$22.31B$4.55B
FY-1$127.23B$23.11B$4.13B
FY0$134.01B$25.56B$2.74B
PeriodOCFCapExFCFSBC
FY-4$4.10B$248.0M
FY-3$2.93B-$920.0M
FY-2$4.21B$1.34B
FY-1$3.13B$1.30B
FY0$3.07B$2.64B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$21.14B
FQ-6
FQ-5$21.60B
FQ-4
FQ-3$23.38B
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity0.0
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Insurance · cohort 5 companies
MetricSRENHActivity
Op margin19.9% medp25 18.5% · p75 33.1%
Net margin13.0% medp25 12.2% · p75 21.2%
Gross margin63.2% medp25 34.2% · p75 67.3%
CapEx / revenue-1.6% medp25 -2.7% · p75 -0.1%
Debt / equity0.0%4.8% medp25 0.3% · p75 25.4%bottom quartile
Observations
IR observations
Mean price target129.78 USD
Median price target130.00 USD
High price target160.00 USD
Low price target114.00 USD
Mean recommendation3.05 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count3.00
Hold count10.00
Sell count6.00
Strong-sell count0.00
Mean EPS estimate15.93 USD
Last actual EPS15.55 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 05:22 UTC#1bed09a3
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 13:33 UTCJob: e2cd12fc